A long-acting 3TC ProTide nanoformulation suppresses HBV replication in humanized mice

Publication date: Available online 24 March 2020Source: Nanomedicine: Nanotechnology, Biology and MedicineAuthor(s): Weimin Wang, Nathan Smith, Edward Makarov, Yimin Sun, Catherine L. Gebhart, Murali Ganesan, Natalia A. Osna, Howard E. Gendelman, Benson J. Edagwa, Larisa Y. Poluektova

Source: Nanomedicine: Nanotechnology, Biology and Medicine - March 25, 2020 Category: Nanotechnology Source Type: research